MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹383 Cr | ₹315 Cr | ₹265 Cr | ₹187 Cr | ₹239 Cr |
What is the latest Profit After Tax of MARKSANS PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹383 Cr |
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹187 Cr |
| Mar2022 | ₹239 Cr |
How is Profit After Tax of MARKSANS PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹383 Cr | 21.51 | |
| Mar2025 | ₹315 Cr | 18.68 | |
| Mar2024 | ₹265 Cr | 42.02 | |
| Mar2023 | ₹187 Cr | -21.68 | |
| Mar2022 | ₹239 Cr | - | |
Compare Profit After Tax of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹13,897.4 Cr | 3.4% | -10.6% | 78.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.4% |
-10.6% |
78.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses